Paper41201971
T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma.
Sywanycz S and 7 others. Mol Cancer Ther, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma. Papers, record 41201971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41201971
- Cell line
- FaDu129 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma.
- PubMed
Connected records5
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Squamous Cell Carcinoma of Head and Neck | Major topic |
| Receptors, G-Protein-Coupled | Major topic |
| Head and Neck Neoplasms | Major topic |
| Humans | |
| Cell Survival | |
| Cell Line, Tumor | |
| Taste Receptors, Type 2 | |
| Animals | |
| Mice | |
| Xenograft Model Antitumor Assays | |
| Cell Proliferation |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI167971 | NIAID NIH HHS | United States | R01AI167971 | PubMed | NIH RePORTER |
| R01 DE034474 | NIDCR NIH HHS | United States | R01DE034474 | PubMed | NIH RePORTER |
| 1R01DE034474 | National Institute of Dental and Craniofacial Research (NIDR) | R01DE034474 | PubMed | NIH RePORTER | |
| R01AI167971 | National Institute of Allergy and Infectious Diseases (NIAID) | R01AI167971 | PubMed | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 40462977 | T2R5 agonist phendione decreases cell viability and induces apoptosis in head and neck squamous cell carcinoma. | https://conductscience.org/library/papers/40462977 |
Source PubMed
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26416778 | Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells. | J Antimicrob Chemother | 2016 | https://conductscience.org/library/papers/26416778 | PubMed |
| 2 | 34503172 | Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503172 | PubMed |
| 3 | 23050025 | Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules. | PLoS One | 2012 | https://conductscience.org/library/papers/23050025 | PubMed |
| 4 | 32172302 | Bitter taste receptors stimulate phagocytosis in human macrophages through calcium, nitric oxide, and cyclic-GMP signaling. | Cell Mol Life Sci | 2021 | https://conductscience.org/library/papers/32172302 | PubMed |
| 5 | 34542294 | Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment. | J Phys Chem Lett | 2021 | https://conductscience.org/library/papers/34542294 | PubMed |
| 6 | 33344890 | Identification and Characterization of Novel Bronchodilator Agonists Acting at Human Airway Smooth Muscle Cell TAS2R5. | ACS Pharmacol Transl Sci | 2020 | https://conductscience.org/library/papers/33344890 | PubMed |
| 7 | 24959857 | Genetically-encoded yellow fluorescent cAMP indicator with an expanded dynamic range for dual-color imaging. | PLoS One | 2014 | https://conductscience.org/library/papers/24959857 | PubMed |
| 8 | 23311874 | Different phenolic compounds activate distinct human bitter taste receptors. | J Agric Food Chem | 2013 | https://conductscience.org/library/papers/23311874 | PubMed |
| 9 | 24396730 | Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery. | Curr Chem Genom Transl Med | 2013 | https://conductscience.org/library/papers/24396730 | PubMed |
| 10 | 28053191 | Extraoral bitter taste receptors in health and disease. | J Gen Physiol | 2017 | https://conductscience.org/library/papers/28053191 | PubMed |
| 11 | 33602906 | Cell death in head and neck cancer pathogenesis and treatment. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33602906 | PubMed |
| 12 | 34496302 | Pharmacological significance of extra-oral taste receptors. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/34496302 | PubMed |
| 13 | 15087236 | Receptors for bitter, sweet and umami taste couple to inhibitory G protein signaling pathways. | Eur J Pharmacol | 2004 | https://conductscience.org/library/papers/15087236 | PubMed |
| 14 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 15 | 29800964 | Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma. | JAMA Otolaryngol Head Neck Surg | 2018 | https://conductscience.org/library/papers/29800964 | PubMed |
| 16 | 35107858 | Functional and genomic comparative study of the bitter taste receptor family TAS2R: Insight into the role of human TAS2R5. | FASEB J | 2022 | https://conductscience.org/library/papers/35107858 | PubMed |
| 17 | 31632299 | Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists. | Front Physiol | 2019 | https://conductscience.org/library/papers/31632299 | PubMed |
| 18 | 22621925 | Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22621925 | PubMed |
| 19 | 39946435 | TAS2R5 screening reveals biased agonism that fails to evoke internalization and downregulation resulting in attenuated desensitization. | PLoS One | 2025 | https://conductscience.org/library/papers/39946435 | PubMed |
| 20 | 7615510 | Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7615510 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42033132 | Cigarette Smoke Exposure Attenuates T2R-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma. | Head Neck | 2026 | https://conductscience.org/library/papers/42033132 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TAS2R5 | 54429 | PubTator's text mining | https://conductscience.org/library/genes/54429 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41201971
GET https://conductscience.org/api/papers/v1/41201971/references?page=2